US Stocks
/
ARS Pharmaceuticals, Inc. Share Price
ARS Pharmaceuticals, Inc. Share Price

ARS Pharmaceuticals, Inc. Share Price

NASDAQ: SPRY
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

ARS Pharmaceuticals, Inc. Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

ARS Pharmaceuticals, Inc. Share Price Chart

$0.00$0.00
L
Show Current Price
H

ARS Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
$-1.74
Revenue (TTM)
$84.28M
Return On Equity (TTM)
-149.92%
Profit Margin
-203.25%
Debt to Equity
0.34
Quarterly Earnings Growth YoY
-308.68%

ARS Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsJun 2024Mar 2025Jun 2025Sep 2025
RevenueN/A$7.97M$15.72M$32.50M
Net Profit-$12.52M-$33.94M-$44.88M-$51.15M
Net Profit MarginN/A-425.69%-285.57%-157.38%
Income ChangeN/A-171.17%-32.24%-13.97%

ARS Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/A$1.32M$30000.00$89.15M$84.28M
Net Profit-$89.48M-$34.68M-$54.37M$8.00M-$171.30M
Net Profit MarginN/A-2635.41%-181216.67%8.97%-203.25%
Income ChangeN/A61.24%-56.75%114.71%-2241.76%

About ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions. The company is involved in the development of neffy, a needle-free and low-dose intranasal epinephrine nasal spray for rescue medication for people with Type I severe allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. The company was founded in 2015 and is headquartered in San Diego, California.

ARS Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %

SPRY Share Price FAQs

What is ARS Pharmaceuticals, Inc. share price today?

chevron-up
ARS Pharmaceuticals, Inc. share price today is $0.00 as on August 9, 2026 at 4:13 pm IST.

What is the 52 week high and 52 week low of ARS Pharmaceuticals, Inc. stock?

chevron-up
52 week high/low data for ARS Pharmaceuticals, Inc. is currently unavailable.

What is SPRY's net income for the last quarter?

chevron-up
SPRY's net income for the last quarter is -0.05B USD.

Can I buy SPRY shares in India?

chevron-up
Yes. You can buy SPRY in India by opening an international trading account.